Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts

Wells A. Messersmith, N. V. Rajeshkumar, Choon Tan Aik, Fei Wang Xiao, Veronica Diesl, Sung E. Choe, Max Follettie, Christina Coughlin, Frank Boschelli, Elena Garcia-Garcia, Fernando Lopez-Rios, Antonio Jimeno, Manuel Hidalgo

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences